By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Aeglea BioTherapeutics 

901 S. MoPac Expressway
Barton Oaks Plaza One
Suite 250

Austin  Texas  78746  U.S.A.
Phone: 512-942-2935 Fax: 512-872-5121


Key Statistics

Ownership: Public

Web Site: Aeglea
Symbol: AGLE


Company News
Aeglea (AGLE) Appoints James Wooldridge, M.D. As Chief Medical Officer 7/11/2017 11:21:55 AM
Aeglea (AGLE) Prices Public Offering Of Common Stock 6/6/2017 10:51:13 AM
Aeglea (AGLE) Announces Proposed Public Offering Of Common Stock 6/6/2017 10:50:14 AM
Aeglea (AGLE) Provides AEB1102 Program And Corporate Update 5/23/2017 11:10:14 AM
Aeglea (AGLE) Provides Corporate Update And Reports First Quarter 2017 Financial Results 5/9/2017 10:03:49 AM
Everything's Bigger in Texas: Aeglea (AGLE) Quickly Growing into Leading Austin Biotech 9/13/2016 7:52:28 AM
Aeglea Announces Closing Of Initial Public Offering And Partial Exercise Of The Underwriters’ Option 4/13/2016 8:06:13 AM
Aeglea Appoints Dr. Anthony Quinn To Board Of Directors 3/15/2016 10:49:15 AM
Aeglea Announces FDA Acceptance Of Its Investigational New Drug Application For AEB1102 For The Treatment Of Hematological Malignancies 3/15/2016 10:46:22 AM
Top 20 Life Science Startups to Watch in the U.S. 1/26/2016 7:46:23 AM